News

Creating more value.
For doctors and patients

Information from science and research

Stay up to date!

Majority stake in HumanOptics AG to be sold to Chinese investor

Ad-hoc-Mitteilung gemäß Art. 17 MAR

Erlangen, August 30, 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company for the production of implants for eye surgery, was informed by its current majority shareholder Medipart AG, Unterägeri/Switzerland, ("Medipart") that Medipart signed a share purchase agreement to sell its stake of 73.4% in the share capital of the Company to a Chinese investor today. The closing of the sale is subject to the fulfillment to customary closing conditions, including approvals by Chinese public authorities.

End of the Ad-hoc-Disclosure

Contact:
HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Telefon: +49 (0) 9131 50665-0
E-Mail: IR@humanoptics.com

Ad-hoc-Disclosure, 30.08.2019

Archive

HumanOptics international

Wichtige Messetermine

OUR

CUSTOMER SERVICE

YOUR

QUESTIONS

Our experts support you with your questions at any time.

*Mandatory field

100 % Made in Germany – Supply ensured

News
News

Our production and delivery capability of our products is assured. At HumanOptics, every business process and every stage of production takes place in Germany. As such, the safety and stability of our inventories is assured, even with the spread of COVID-19. From development to production and shipping, all of our processes are located at our […]